Uchenab Logo
Uchenab Logo
Uchenab Logo

The University of Chenab

  • Our Faculties
  • Dr. Kanwal

Dr. Kanwal (She/Her)

Academic Position:

Assistant Professor

Teaching Interests:

Pharmaceutical Chemistry

Fields of Research (FoR):

Medicinal Chemistry/Drug Discovery/Synthetic Organic Chemistry

Keywords:

Medicinal Chemistry; Synthetic Organic Chemistry; Structure-Activity Relationship; Drug Discovery; Bioactive Molecules

Department:

Department of Pharmacy

Faculty:

Faculty of Pharmaceutical Sciences

Contact Details:

  • Email:
  • Mobile:
  • Landline/Extension:
  • Office Location:

Social Links

Student Advising Schedule:

Monday- Friday, 3-5 PM

BIOGRAPHY

Dr. Kanwal received her PhD in Chemistry from the H.E.J. Research Institute of Chemistry, International Centre for Chemical and Biological Sciences (ICCBS), University of Karachi, where her doctoral research focused on the synthesis of indole and tryptamine derivatives and evaluation of their biological activities. She subsequently completed a postdoctoral research fellowship at the Institute of Climate Adaptation Marine Biotechnology (ICAMB), Universiti Malaysia Terengganu, Malaysia, gaining international research experience and strengthening her expertise in interdisciplinary research and scientific communication. Dr Kanwal is a synthetic organic and medicinal chemist specializing in the design, synthesis, and characterization of biologically active heterocyclic compounds. Her work integrates organic and heterocyclic synthesis with structure–activity relationship studies to develop and investigate bioactive molecules with potential therapeutic applications. She has authored 55 research publications, including 52 Scopus-indexed and 51 Web of Science-indexed publications, with more than 1,250 Google Scholar citations and a Google Scholar h-index of 23. In addition to her research activities, Dr Kanwal has teaching experience at the University of Karachi. She is particularly interested in integrating research and teaching to encourage students to develop strong conceptual understanding, problem-solving skills, and research-oriented thinking.

ACADEMIC APPOINTMENTS

No.DesignationSchool/Institute/UniversityDuration
1Assistant ProfessorUniversity of Chenab2026-Present
2Postdoctoral FellowICAMB, University Malaysia Terengganu2019-2021
3Teaching AssociateDepartment of Chemistry, University of Karachi2019
4Instructor/Study Guide2National Chemistry Talent Contest, HEJRIC, University of Karachi2018

MY QUALIFICATIONS

No.Degree / Program of Study NameAwarding Body/University/InstituteYear
1M. Phil leading to PhDH.E.J. Research Institute of Chemistry, ICCBS, University of Karachi, Pakistan2017
2MScUniversity of Karachi, Pakistan2010
3BScUniversity of Karachi, Pakistan2007
4HScBISE, Karachi2005
5SScBSEK, Karachi2003

MY RESEARCH ACTIVITIES: JOURNALS ARTICLES / BOOK CHAPTERS / PATENTS

No.TitleDetails
1Synthesis of new bis(dimethylamino)benzophenone hydrazone for diabetic management: In-vitro and in-silico approach. M. Khan, G. Ahad, A. Alam, S. Ullah, A. Khan, Kanwal, U. Salar, A. Wadood, A. Ajmal, K. M. Khan, S. Perveen, J. Uddin, A. Al-Harrasi.Heliyon, 10, 1, e23323, 2024.
2Unsymmetrical thiourea derivatives: synthesis and evaluation as promising antioxidant and enzyme inhibitors. B. Bano, Kanwal, S. Hameed, M. Lateef, A. Wadood, S. Shams, S. Hussain, N. U. Ain, S. Perveen, M. Taha, K. M. Khan.Future Medicinal Chemistry, 16, 6, 2023.
3Isatin thiazoles as antidiabetic: Synthesis, in vitro enzyme inhibitory activities, kinetics, and in silico studies. M. Solangi, Kanwal, K. M. Khan, S. Chigurupati, F. Saleem, U. Qureshi, Z. Ul-Haq, A. Jabeen, S. G. Felemban, F. Zafar, S. Parveen, M. Taha, and S. Bhatia.Archiv der Pharmazie, 355(6), 2100481, 2022. (https://doi.org/10.1002/ardp.202100481)
4Andriani, Y., Ramli, N. M., Musa, N. S., Kanwa.l, Mohamad, H., Amir, H., & Assaw, S. Anti-inflammatory activity of phenolic-rich fraction of Pandanus tectorius fruits via reduction of NO production on lipopolysaccharide-stimulated RAW264. 7 cell lines and formalin-induced paw Oedema.The Thai Journal of Pharmaceutical Sciences, 46(5), 551-560, 2022.
5Biology-oriented drug synthesis of nitrofurazone derivatives: Their α-glucosidase inhibitory activity and molecular docking studies. S. Wahid, S. Jahangir, M. A. Versiani, K. M. Khan, Y. Y. Sung, J. Iqbal A. Wadood, Kanwal, A. U. Rehman, Arshia, M. Uzair, I. A. Khan, M. Taha, S. Perveen.Arabian Journal of Chemistry, 15, 103806, 2022. (https://doi.org/10.1016/j.arabjc.2022.103806).
6Indole-3-acetamides: As potential antihyperglycemic and antioxidant agents; synthesis, in vitro α-amylase inhibitory activity, structure-activity relationship, and in silico studies. Kanwal, K. M. Khan, S. Chigurupati, F. Ali, M. Younus, M. Aldubayan, S. Perveen.ACS Omega, 6(3), 2264-2275, 2021.
7Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies. F. Saleem, Kanwal, K. M. Khan, S. Chigurupati, M. Solangi, A. R. Nemala, M. Mushtaq, Z. Ul-Haq, M. Taha, S. Perveen.Bioorganic Chemistry, 106, 104489, 2021. (doi.org/10.1016/j.bioorg.2020.104489).
8Synthesis of chalcones as potential α‐glucosidase inhibitors, in‐vitro and in‐silico studies. A. Mukhtar, S. Shah, Kanwal, K. M. Khan, S. U. Khan, S. Zaib, J. Iqbal, S. Parveen, M.Taha, S. Hussain, and S. Hameed.ChemistrySelect, 6(37), 9933-9940, 2021. (https://doi.org/10.1002/slct.202102434).
9Substituted benzimidazole analogues as potential α-amylase inhibitors and radical scavengers. A. A. Akande, U. Salar, K. M. Khan, S. Syed, S. A. Aboaba, S. Chigurupati, A. Wadood, M. Riaz, M. Taha, S. Bhatia, Kanwal, S. Shamim, and S. Perveen.ACS Omega, 6(35), 22726-22739, 2021. (doi.org/10.1021/acsomega.1c03056)
10Biology-oriented drug synthesis (BIODS), in vitro urease inhibitory activity, and in silico studies on ibuprofen derivatives. F. Seraj, Kanwal, K. M. Khan, A. Khan, M. Ali, R. Khalil, Z. Ul-Haq, S. Hameed, M. Taha, U. Salar, S. Perveen.Molecular Diversity, 25, 143-157, 2021. (https://doi.org/10.1007/s11030-019-10032-x).
11Sulfonamides and Sulphonyl Ester of Quinolines as Non-Acidic, Non-Steroidal, Anti-inflammatory Agents. B. Bano, Kanwal, K. M. Khan, A. Jabeen, A. Faheem, M. Taha, S. M. Haider and S. Perveen.Letters in Drug Design and Discovery, 18(2), 112-120, 2021. (http://dx.doi.org/10.2174/1570180817999201005201308).
12Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae. Kanwal, M. R. Mungroo, A. Anwar, F. Ali, S. Khan, M. A. Abdullah, R. Siddiqui, K. M. Khan, N. A. Khan.Experimental Parasitology, 2020, 218, 107979, 2020. (https://doi.org/10.1016/j.exppara.2020.107979).
13Synthesis of new indazole based dual inhibitors of α-glucosidase and α-amylase enzymes, their in vitro, in silico and kinetics studies. R. Rafique, K. M. Khan, Arshia, Kanwal, S. Chigurupati, A. Wadood, A. U. Rehman, A. Karunanidhi, S. Hameed, Muhammad Taha, M. Al-Rashida.Bioorganic Chemistry, 94, 103195, 2020. (https://doi.org/10.1016/j.bioorg.2019.103195).
144-Oxycoumarinyl linked acetohydrazide Schiff bases as potent urease inhibitors. F. Naz, Kanwal, M. Latif, U. Salar, K. M. Khan, M. al-Rashida, I. Ali, B. Ali, M. Taha, S. Perveen.Bioorganic Chemistry, 105, 104365, 2020. (doi.org/10.1016/j.bioorg.2020.104365).
15Syntheses, in vitro α-amylase and α- glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies. E. O. Yeye, Kanwal, K. M. Khan, S. Chigurupati, A. Wadood, A. Ur Rehman, S. Perveen, M. K. Maharajan, S. Shamim, S. Hameed, S. A. Aboaba, M. Taha.Bioorganic and Medicinal Chemistry, 28, 115467, 2020. (https://doi.org/10.1016/j.bmc.2020.115467).
16Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, α-glucosidase inhibitory activity and molecular docking studies. M. Solangi, Kanwal, K. M. Khan, F. Saleem, S. Hameed, J. Iqbal, S. Ullah Khan, U. Qureshi, Z. Ul- Haq, M. Taha, and S. Perveen.Bioorganic and Medicinal Chemistry, 28, 115605, 2020.
17Discovery of New N-hydrazinecarbothioamide indazole Hhybrids: As potential radical (ABTS and DPPH) scavengers. R. Rafique, Arshia, Kanwal, K. M. Khan, S. Chigurupati, U. Salar, M. Taha, S. Perveen.Letters in Drugs Design and Discovery, 17, 1177-1185, 2020. (10.2174/1570180817999200424074455).
18Analgesic and Anti-inflammatory Potential in Misopates orontium. M. Ajaib, K. M. Khan, Kanwal, S. Perveen, and S. Shah.Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences, 57, 69-74, 2020. (https://ppaspk.org/index.php/PPAS-B/article/view/75/63).
19Indane-1,3-diones: as potential and selective α-glucosidase inhibitors, their synthesis, in vitro and in silico studies. A. Mukhtar, S. Shah, Kanwal, S. Hameed, K. M. Khan, S. Ullah Khan, S. Zaib, J. Iqbal, S. Parveen.Medicinal Chemistry, 2020. (10.2174/1573406416666200826102051).
20Synthesis of new indazole based dual inhibitors of α- glucosidase and α-amylaseenzymes, their in vitro, in silico and kinetics studies. R. Rafique, K. M. Khan, Arshia, Kanwal, S. Chigurupati, A. Wadood, A. U. Rehman, A. Karunanidhi, S. Hameed, Muhammad Taha, M. Al-Rashida.Bioorganic Chemistry, 94, 103195, 2020. (https://doi.org/10.1016/j.bioorg.2019.103195).
21Dihydropyrimidones: A ligands urease recognition study and mechanistic insight through in vitro and in silico approach. F. A. Khan, S. Shamim, N. Ullah. M. A. Lodhi, K. M. Khan, Kanwal, F. Ali, S. G. Afridi, S. Perveen, A. Khan.Medicinal Chemistry Research, 2020. (doi.org/10.1007/s00044-020- 02643-z).
22Dihydropyridines as potential α-amylase and α-glucosidase inhibitors: Synthesis, in vitro and in silico studies. H. Yousuf, S. Shamim, K. M. Khan, S. Chigurupati, Kanwal, S. Hameed, M. N. Khan, M. Taha, Minhajul Arfeen.Bioorganic Chemistry, 95, 103581, 2020. (DOI: 10.1016/j.bioorg.2020.103581).
23Novel Azoles as Antiparasitic Remedies against Brain-Eating Amoebae. A. Anwar, M. R. Mungroo, S. Khan, I. Fatima, R. Rafique, Kanwal, K. M. Khan, R. Siddiqui and N. A. Khan.Antibiotics, 9(4), 188. (https://doi.org/10.3390/antibiotics9040188), 2020.
24Effective photocatalytic methylene orange dye degradation ability in coloured textile contaminated water by highly efficient catalyst Schiff-based resin-encapsulated supported on TiO2@SiO2 metal oxide nanoparticles. N. L. Rajput, M. A. Mughal, A. Balouch, K. M. Khan, S. A. Tunio, Kanwal, S. Sohu.International Journal of Environmental Analytical Chemistry. (doi.org/10.1080/03067319.2020.1772770), 2020.
25Acetylcholinesterase and butyrylcholinesterase inhibitory activities of 5 -arylidene-N, N- diethylthiobarbiturates. M. Khan, M. U. Rehman, N. Qadir, M. Ashraf, T. Ismail, M. Ismail, Kanwal, U. Salar, K. M. Khan, S. Perveen.Journal of The Chemical Society Pakistan, 42, 134-140, 2020.
26Antiglycation Activity of N,N-Diethylthiobarbiturates derivatives. M. Khan, G. Ahad, A. Khan, U. Salar, S. Shah, S. M. Salman, Kanwal, K. M. Khan.Letters in Drugs Design and Discovery, 17, 2020. (10.2174/1570180816666190516111516).
27Atenolol thiourea hybrid as potent urease inhibitors: Design, biology-oriented drug synthesis, inhibitory activity screening, and molecular docking studies. S. Wahid, S. Jahangir, M. A. Versiani, K. M. Khan, U. Salar, M. Ashraf, U. Farzand, A. Wadood, Kanwal, A-ur-Rehaman, Arshia, M. Taha, S. Perveen.Bioorganic Chemistry, 94, 103359, 2020. (https://doi.org/10.1016/j.bioorg.2019.103359).
28Aryl-oxadiazole Schiff bases: Synthesis, α- glucosidase in vitro inhibitory activity and their in silico studies. H. Ullah, F. Rahim, M. Taha, R. Hussain, N. Tabassum, A. Wadood, M. Nawaz, A. Mosaddik, S. Imran, Z. Wahab, G. A. Miana, Kanwal, K. M. Khan.Arabian Journal of Chemistry, 2020. (https://doi.org/10.1016/j.arabjc.2020.01.005).
29Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking studies 2-amino-1,3,4-oxadiazole derivatives. H. Ullah, F. Rahim, M. Taha, R. Hussain, A. Wadood, M. Nawaz, Z. Wahab, Kanwal, K. M. Khan.Medicinal Chemistry, 2020. (doi: 10.2174/1573406415666190612150447).
30Antiamoebic activity of 3-aryl-6,7-dimethoxyquinazolin-4(3H)-one library against Acanthamoeba castellanii. M. S. Shahbaz, A. Anwar, S. M. Saad, Kanwal, A. Anwar, K. M. Khan, R. Siddiqui, N. A. Khan.Parasitology Research, 2020. (doi.org/10.1007/s00436-020-06710-7).
31Syntheses, in vitro urease inhibitory activities of urea and thiourea derivatives of tryptamine, their molecular docking, and cytotoxic studies. Kanwal, M. Khan, Arshia, K. M. Khan, S. Parveen, M. Shaikh, N. Fatima, M. I. Choudhary.Bioorganic Chemistry, 83, 595-610, 2019. (https://doi.org/10.1016/j.bioorg.2018.10.070).
32Schiff bases of tryptamine as potent inhibitors of nucleoside triphosphate diphosphohydrolases (NTPDases): Structure-activity relationship. Kanwal, K. M. Khan, U. Salar, S. Afzal, A. Wadood, M. Taha, S. Perveen, H. Khan, J. Lecka, J. Sévigny, J. Iqbal.Bioorganic Chemistry, 82, 253-266, 2019. (https://doi.org/10.1016/j.bioorg.2018.10.046).
33Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies. S. Hameed, Kanwal, F. Seraj, R. Rafique, S. Chigurupati, A. Wadood, A. ur Rehman, V. Venugopal, U. Salar, M. Taha, K. M. Khan.European Journal of Medicinal Chemistry, 183, 111677, 2019. (https://doi.org/10.1016/j.ejmech.2019.111677).
34Synthesis and in vitro anti-proliferative capabilities of steroidal thiazole and indole derivatives. F. Shamim, Kanwal, F. A. Khan, M. Taha, K. M. Khan, Arshia.Journal of Saudi Chemical Society, 23, 775-780, 2019. (https://doi.org/10.1016/j.jscs.2019.05.001).
35Novel antiacanthamoebic compounds belonging to Quinazolinones. A. Anwar, M. S. Shahbaz, S. M. Saad, Kanwal, K. M. Khan, R. Siddiqui, and N. A. Khan.European Journal of Medicinal Chemistry, 182, 111575, 2019. (https://doi.org/10.1016/j.ejmech.2019.111575).
36Synthesis and in vitro urease inhibitory activity of benzohydrazide derivatives, in silico and kinetic studies. A. Abbas, B. Ali, Kanwal, K. M. Khan, J. Iqbal, S. ur Rahman, S. Zaib, S. Perveen.Bioorganic Chemistry, 82, 163-177, 2019. (https://doi.org/10.1016/j.bioorg.2018.09.036).
37Tyrosinase inhibitory activity of S-naproxen derivatives. G. Mohiuddin, K. M. Khan, U. Salar, Kanwal, M. A Lodhi, F. Begum, S. Perveen.Letters in Drugs Design and Discovery, 16, 1276- 1285, 2019. DOI: 10.2174/1570180816666190611162355.
38Biology-oriented drug synthesis (BIODS), in vitro urease inhibitory activity, and in silico study of S-naproxen derivatives. G. Mohiuddin, K. M. Khan, U. Salar, Kanwal, M. A. Lodhi, A. Wadood, M. Riaz, S. Perveen.Bioorganic Chemistry, 83, 29-46, 2019. (https://doi.org/10.1016/j.bioorg.2018.10.021).
39Synthesis, Crystallographic, Monoclinic, Inflexible, Antifungal Assessment of Schiff based resin. N. L. Rajput, M. A. Moghal, A. H. Moghal, K. M. Khan, A. Balouch, Kanwal.Sindh University Research Journal (Science Series), 51, 249-258, 2019.
40Green synthesis, characterization, DPPH and ferrous ion-chelating (FIC) activity of tetrakis-Schiff’s bases of terephthalaldehyde. M. Khan, U. Ali, A. Ur Rahman, M. Ibrahim, A. Hameed, M. Asif, Z. Hussain, Kanwal, K. M. Khan, S. Perveen, M. ur Rehman.Letters in Drug Design & Discovery, 16, 249-255, 2019. (https://doi.org/10.2174/1570180815666180531101404).
41ROS inhibitory activity and cytotoxicity evaluation of benzoyl, acetyl, alkyl ester, and sulfonate ester substituted coumarin derivatives. U. Salar, K. M. Khan, A. Jabeen, A Faheem, F. Naqvi, S. Ahmed, E. Iqbal, F. Ali, Kanwal, S. Perveen.Medicinal Chemistry, 2019. (doi: 10.2174/1573406415666190826153001).
42Benzylidine indane-1,3-diones: As novel urease inhibitors; synthesis, in vitro, and in silico studies. B. Bano, Kanwal, K. M. Khan, F. Begum, M. A. Lodhi, U. Salar, R. Khalil, Z. Ul-Haq, S. Perveen.Bioorganic Chemistry, 81, 658-671, 2018. (https://doi.org/10.1016/j.bioorg.2018.09.030).
43Synthesis, in vitro urease inhibitory activity, and molecular docking studies of thiourea and urea derivatives. B. Bano, Kanwal, K. M. Khan, A. Lodhi, U. Salar, F. Begum, M. Ali, M. Taha, S. Perveen.Bioorganic Chemistry, 80, 129-144, 2018. (https://doi.org/10.1016/j.bioorg.2018.06.007).
44Synthesis of 4- Substituted Ethers of Benzophenone and their Antileishmanial Activity. Arshia, F. Ahad, N. Ghouri, Kanwal, K. M. Khan, S. Perveen, M. I. Choudhary.Royal Society Open Sciences, 5, 171771, 2018. (https://doi.org/10.1098/rsos.171771).
45Synthetic nicotinic/isonicotinic thiosemicarbazides: In vitro urease inhibitory activities and molecular docking studies. B. Ali, K. M. Khan, Arshia, Kanwal, S. Hussain, S. Hussain, M. Ashraf, M. Riaz, A. Wadood, S. Perveen.Bioorganic Chemistry, 79, 34-45, 2018. (https://doi.org/10.1016/j.bioorg.2018.04.004).
461-[(4′-Chlorophenyl) carbonyl-4-(aryl) thiosemicarbazide derivatives as potent urease inhibitors: Synthesis, in vitro and in silico studies. B. Ali, K. M. Khan, U. Salar, Kanwal, S. Hussain, M. Ashraf, M. Riaz, A. Wadood, M. Taha, S. Perveen.Bioorganic Chemistry, 79, 363-371, 2018. (https://doi.org/10.1016/j.bioorg.2018.05.017).
472-Aryl benzimidazoles: Synthesis, In vitro α- amylase inhibitory activity, and molecular docking study. A. A. Adegboye, K. M. Khan, U. Salar, S. A. Aboaba, Kanwal, S. Chigurupati, I. Fatima, M. Taha, A. Wadood, J. I. Mohammad, H. Khan, S. Perveen.European Journal of Medicinal Chemistry, 150, 248-260, 2018. (https://doi.org/10.1016/j.ejmech.2018.03.011).
48Synthesis, Structural Characterization, and Antioxidant Activities of 2,4 -Dinitrophenyl-Hydrazone Derivatives. G. Ahad, M. Khan, A. Khan, M. Ibrahim, U. Salar, Kanwal, K. M. Khan, S. Perveen.Journal of Chemical Society of Pakistan, 40, 961-973, 2018.
49New indole based hybrid oxadiazole scaffolds with N-substituted acetamides: As potent anti-diabetic agents. M. Nazir, M. A. Abbasi, A.-ur-Rehman, S. Z. Siddiqui, K. M. Khan, Kanwal, U. Salar, M. Shahid, M. Ashraf, M. A. Lodhi, F. A. Khan.Bioorganic Chemistry, 81, 253-263, 2018. (https://doi.org/10.1016/j.bioorg.2018.08.010).
50Chalcones and bis-chalcones: As potential α-amylase inhibitors; synthesis, in vitro screening, and molecular modelling studies. A. T. Bale, K. M. Khan, U. Salar, S. Chigurupati, T. Fasina, F. Ali, Kanwal, A. Wadood, M. Taha, S. S. Nanda, M. Ghufran, S. Perveen.Bioorganic Chemistry, 79, 179-189, 2018. (https://doi.org/10.1016/j.bioorg.2018.05.003).
51Synthesis, β-Glucuronidase Inhibition, and Molecular Docking Studies of 1,2,4 -Triazole Hydrazones. W. Jamil, D. Kumari, M. Taha, M. N. Khan, M. S. Baharudin, M. Ali, Kanwal, M. S. Lashari, K. M. Khan.Journal of the Iranian Chemical Society, 15, 2441-2454, 2018. (doi.org/10.1007/s13738- 018-1433-9).
52Synthesis, structure-activity relationship and molecular docking studies of 3-O- flavonol glycosides as cholinesterase inhibitors. E. U. Mughal, A. Javid, A. Sadiq, S. Murtaza, M. N. Zafar, B. A. Khan, S. H. Sumra, M. N. Tahir, Kanwal, K. M. Khan.Bioorganic and Medicinal Chemistry, 26, 3696- 706, 2018. (https://doi.org/10.1016/j.bmc.2018.05.050)
53Synthesis, in vitro ß-glucuronidase inhibitory potential and molecular docking studies of quinolones. B. Bano, Arshia, K. M. Khan, Kanwal, B. Fatima, M. Taha, N. H. Ismail, A. Wadood, M. Ghufran, S. Perveen.European Journal of Medicinal Chemistry, 139, 849-864, 2017. (https://doi.org/10.1016/j.ejmech.2017.08.052).
54Anti-inflammatory Activity of 3-Thiazolyl Coumarins. U. Salar, K. M. Khan, A. Jabeen, Bakhtawar, A. Faheem, F. Ali, S. Syed, Kanwal, and S. Perveen.Journal of Chemical Society of Pakistan, 39, 578-585, 2017.
55A Facile Route towards the Synthesis of 2-(1H-indol-3-yl)-acetamides Using 1,1-Carbonyldiimidazole. Kanwal, K. M. Khan, B. Fatima, B. Bano and U. Salar.Journal of Chemical Society of Pakistan, 38, 771-774, 2016.
56Mass production and factors affecting biosurfactant productivity using bioreactors, Kanwal, H. A. Hussein, K. M. Khan, and M. A. Abdullah.Green Sustainable Process for Chemical and Environmental Engineering and Science, 379-398, 2021. (https://doi.org/10.1016/B978-0-12-823380-1.00015-0).Book Chapter
57Management of inflammatory diseases through natural products of plant origin, Y. Andriani, N. S. Musa, N. M. Ramli, E. Oksal, M. Sababathy, Kanwal, H. Mohamad, J. Saidin, I. Pangestika, H. Amir, M. N. I. Kassim, D. F. Syamsumir, and S. Assaw.Navigating the Blue Frontier Emerging Research and Therapeutics in Biotechnology, 5-29, 2023.Book Chapter
58Optimization, characterization, and in vitro study of P. tectorius-SNEDDS as an antihypercholesterolemic agent via the inhibition of HMG-CoA reductase activity.Under Revision
59Improving the antiatherosclerosis activity of Pandanus tectorius on high-cholesterol Sprague Dawley rats by SNEDDS carrier via the inhibition of HMG-CoA reductase activityUnder Revision

MY RESEARCH SUPERVISION:

Areas of Supervision 

Currently Supervising

Student NameResearch TopicAffiliation

Completions

Student NameResearch TopicAffiliation